Assessment of Haematological and Immunological Effect after New Direct ‎Acting Antiviral Drugs in Chronic Hepatitis C Virus Egyptian Patients

Abstract

CD+4, CD3+CD4+, CD3+CD8+, CD3−CD8+ cells)) at 3-months post-therapy. Conclusion: Although combination of Sofosbuvir and Dacltasvir was safe and effective in management of chronic HCV infection but its effect on the immune cells is still unclear. Further studies are in need to confirm such results.